{"id":538121,"date":"2021-09-14T12:59:01","date_gmt":"2021-09-14T16:59:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\/"},"modified":"2021-09-14T12:59:01","modified_gmt":"2021-09-14T16:59:01","slug":"humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\/","title":{"rendered":"Humanigen Announces Participation and Presentation at Multiple Conferences in September"},"content":{"rendered":"

<\/p>\n

Humanigen Announces Participation and Presentation at Multiple Conferences in September<\/b><\/p>\n

BURLINGAME, Calif.–(BUSINESS WIRE<\/a>)–
\nHumanigen, Inc. (Nasdaq: HGEN) (\u201cHumanigen\u201d), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called \u2018cytokine storm,\u2019 announced that management will present and participate at multiple virtual investor conferences in September 2021. Details of the conferences are as follows:\n<\/p>\n

Baird Global Healthcare Conference<\/b><\/p>\n

\nCameron Durrant, Chairman & CEO, will provide a corporate update at 5:30pm EDT on September 14, 2021. Access is limited, by the host of the conference, on an invitation only basis. Please contact your Baird representative for information on how to access the meeting.\n<\/p>\n

H.C. Wainwright 23rd Annual Global Investment Conference<\/b><\/p>\n

\nCameron Durrant, Chairman & CEO participated in a panel to discuss \u201cBest Practices Planning for the Next Pandemic\u201d, which was pre-recorded and will be available starting at 12pm EDT on September 15, 2021.\n<\/p>\n

\nWebcast: https:\/\/journey.ct.events\/view\/df4da74c-0a2c-499c-a5be-13f994a0d28f<\/a><\/p>\n

Oppenheimer Fall Healthcare Life Sciences & MedTech Summit<\/b><\/p>\n

\nPresentation date: September 22, 2021
\n
Presentation time: 2:05 ET\n<\/p>\n

\nWebcast: Webcast link: https:\/\/wsw.com\/webcast\/oppenheimer16\/hgen\/2752454
\n<\/a>
The webcast will be archived for 90 days under the Investor Relations section of the company\u2019s website at www.humanigen.com<\/a>.\n<\/p>\n

Cantor Global Healthcare 2021<\/b><\/p>\n

\nPresentation date: September 27, 2021
\n
Presentation time: 4:40 ET\n<\/p>\n

\nWebcast link: https:\/\/wsw.com\/webcast\/cantor12\/hgen\/2064020
\n<\/a>
The webcast will be archived for 90 days under the Investor Relations section of the company\u2019s website at www.humanigen.com<\/a>.\n<\/p>\n

About Humanigen<\/b><\/p>\n

\nHumanigen, Inc. (Nasdaq: HGEN) (\u201cHumanigen\u201d), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called \u2018cytokine storm\u2019. Lenzilumab is a first-in class antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). Results from preclinical models indicate GM-CSF is an upstream regulator of many inflammatory cytokines and chemokines involved in the cytokine storm. Early in the COVID-19 pandemic, investigation showed high levels of GM-CSF secreting T cells were associated with disease severity and intensive care unit admission. Humanigen\u2019s Phase 3 LIVE-AIR study suggests early intervention with lenzilumab may prevent consequences of a full-blown cytokine storm in hospitalized patients with COVID-19. Humanigen has submitted lenzilumab to Medicines and Health Regulatory Agency in the United Kingdom for a rolling review towards potential Marketing Authorization. Humanigen is developing lenzilumab as a treatment for cytokine storm associated with COVID-19 and, CD19-targeted CAR-T cell therapies, and exploring the effectiveness of lenzilumab in other inflammatory conditions such as acute Graft versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplantation, eosinophilic asthma, and rheumatoid arthritis. For more information, visit www.humanigen.com<\/a> and follow Humanigen on LinkedIn, Twitter, and Facebook.\n<\/p>\n

Forward-Looking Statements<\/b><\/p>\n

\nAll statements other than statements of historical facts contained in this press release are forward-looking statements. Forward-looking statements reflect management’s current knowledge, assumptions, judgment, and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, they give no assurance that such expectations will prove to be correct, and you should be aware that actual events or results may differ materially from those contained in the forward- looking statements. Words such as “will,” “expect,” “intend,” “plan,” “potential,” “possible,” “goals,” “accelerate,” “continue,” and similar expressions identify forward-looking statements, including, without limitation, statements regarding our plans relating to lenzilumab.\n<\/p>\n

\nForward-looking statements are subject to a number of risks and uncertainties including, but not limited to, the risks inherent in our lack of profitability and need for additional capital to grow our business; our dependence on partners to further the development of our product candidates; the uncertainties inherent in the development, attainment of the requisite regulatory authorizations and approvals and launch of any new pharmaceutical product; the outcome of pending or future litigation; and the various risks and uncertainties described in the “Risk Factors” sections of our latest annual and quarterly reports and other filings with the SEC.\n<\/p>\n

\nAll forward-looking statements are expressly qualified in their entirety by this cautionary notice. You should not rely upon any forward-looking statements as predictions of future events. We undertake no obligation to revise or update any forward-looking statements made in this presentation to reflect events or circumstances after the date hereof, to reflect new information or the occurrence of unanticipated events, to update the reasons why actual results could differ materially from those anticipated in the forward-looking statements, in each case, except as required by law.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210914005963\/en\/<\/a><\/span><\/p>\n

Humanigen Investor Relations
\n<\/b>
Ken Trbovich
\n
Humanigen
\n
trbo@humanigen.com
\n<\/a>
650-410-3206\n<\/p>\n

KEYWORDS:<\/b> California United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Health Clinical Trials<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Humanigen Announces Participation and Presentation at Multiple Conferences in September BURLINGAME, Calif.–(BUSINESS WIRE)– Humanigen, Inc. (Nasdaq: HGEN) (\u201cHumanigen\u201d), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called \u2018cytokine storm,\u2019 announced that management will present and participate at multiple virtual investor conferences in September 2021. Details of the conferences are as follows: Baird Global Healthcare Conference Cameron Durrant, Chairman & CEO, will provide a corporate update at 5:30pm EDT on September 14, 2021. Access is limited, by the host of the conference, on an invitation only basis. Please contact your Baird representative for information on how to access the meeting. H.C. Wainwright 23rd Annual Global Investment Conference Cameron Durrant, Chairman & CEO participated in a panel to … <\/p>\n

Continue reading “Humanigen Announces Participation and Presentation at Multiple Conferences in September”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-538121","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nHumanigen Announces Participation and Presentation at Multiple Conferences in September - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Humanigen Announces Participation and Presentation at Multiple Conferences in September - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Humanigen Announces Participation and Presentation at Multiple Conferences in September BURLINGAME, Calif.–(BUSINESS WIRE)– Humanigen, Inc. (Nasdaq: HGEN) (\u201cHumanigen\u201d), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called \u2018cytokine storm,\u2019 announced that management will present and participate at multiple virtual investor conferences in September 2021. Details of the conferences are as follows: Baird Global Healthcare Conference Cameron Durrant, Chairman & CEO, will provide a corporate update at 5:30pm EDT on September 14, 2021. Access is limited, by the host of the conference, on an invitation only basis. Please contact your Baird representative for information on how to access the meeting. H.C. Wainwright 23rd Annual Global Investment Conference Cameron Durrant, Chairman & CEO participated in a panel to … Continue reading "Humanigen Announces Participation and Presentation at Multiple Conferences in September"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-14T16:59:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210914005963r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Humanigen Announces Participation and Presentation at Multiple Conferences in September\",\"datePublished\":\"2021-09-14T16:59:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\\\/\"},\"wordCount\":770,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210914005963r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\\\/\",\"name\":\"Humanigen Announces Participation and Presentation at Multiple Conferences in September - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210914005963r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-09-14T16:59:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210914005963r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210914005963r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Humanigen Announces Participation and Presentation at Multiple Conferences in September\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Humanigen Announces Participation and Presentation at Multiple Conferences in September - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\/","og_locale":"en_US","og_type":"article","og_title":"Humanigen Announces Participation and Presentation at Multiple Conferences in September - Market Newsdesk","og_description":"Humanigen Announces Participation and Presentation at Multiple Conferences in September BURLINGAME, Calif.–(BUSINESS WIRE)– Humanigen, Inc. (Nasdaq: HGEN) (\u201cHumanigen\u201d), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called \u2018cytokine storm,\u2019 announced that management will present and participate at multiple virtual investor conferences in September 2021. Details of the conferences are as follows: Baird Global Healthcare Conference Cameron Durrant, Chairman & CEO, will provide a corporate update at 5:30pm EDT on September 14, 2021. Access is limited, by the host of the conference, on an invitation only basis. Please contact your Baird representative for information on how to access the meeting. H.C. Wainwright 23rd Annual Global Investment Conference Cameron Durrant, Chairman & CEO participated in a panel to … Continue reading \"Humanigen Announces Participation and Presentation at Multiple Conferences in September\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-14T16:59:01+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210914005963r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Humanigen Announces Participation and Presentation at Multiple Conferences in September","datePublished":"2021-09-14T16:59:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\/"},"wordCount":770,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210914005963r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\/","name":"Humanigen Announces Participation and Presentation at Multiple Conferences in September - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210914005963r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-09-14T16:59:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210914005963r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210914005963r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humanigen-announces-participation-and-presentation-at-multiple-conferences-in-september\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Humanigen Announces Participation and Presentation at Multiple Conferences in September"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/538121","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=538121"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/538121\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=538121"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=538121"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=538121"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}